Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Allergic Contact Dermatitis: early-phase trial registry
1 of 4 indexed Allergic Contact Dermatitis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Allergic Contact Dermatitis: 4 US clinical trials tracked, 1 recruiting.
Allergic Contact Dermatitis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Wright State Physicians, running 1 of these trials.
Enrollment posture brief
Registry condition allergic-contact-dermatitis
OPEN 1 | RECR 25% | LATE 1 | EARLY 3 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Allergic Contact Dermatitis lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Allergic Contact Dermatitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Allergic Contact Dermatitis is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Wei-Che Ko
NCT05535738
The Effects of Dupilumab on Allergic Contact Dermatitis
Brigham and Women's Hospital
NCT03935971
Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects
Wright State Physicians
NCT03945760
Study of Apremilast in Atopic or Contact Dermatitis
Tufts Medical Center
NCT00931242
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Allergic Contact Dermatitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Allergic Contact Dermatitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Allergic Contact Dermatitis page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Allergic Contact Dermatitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Wright State Physicians sponsors the most Allergic Contact Dermatitis trials on record, review their full trial history before evaluating a specific study. See Wright State Physicians's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Allergic Contact Dermatitis condition card totals 4 registered trials; most-linked intervention Dupilumab; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.